Cost-effectiveness of radiofrequency renal denervation for uncontrolled and resistant hypertension in The Netherlands
Over lifetime, RF RDN was found cost-effective in the Dutch healthcare system, with an ICER substantially below the applicable willingness-to-pay threshold, while providing meaningful reductions in clinical events for uncontrolled including resistant hypertension patients.
Authors
- Wilko Spiering (ORCID: https://orcid.org/0000-0002-2493-6407)
- Joost Daemen (ORCID: https://orcid.org/0000-0001-8628-1410)
- Jan B. Pietzsch (ORCID: https://orcid.org/0000-0002-5078-1939)
- Khoa N. Cao (ORCID: https://orcid.org/0000-0002-2834-1072)
- Kari Saville (ORCID: https://orcid.org/0009-0005-9375-207X)
- Anne M. Ryschon
- Jeroen van Kuijck
Institutions
- Medtronic (Ireland) (IE)
- University Medical Center Utrecht (NL)
- Medtronic (Netherlands) (NL)
- ATUM (United States) (US)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Blood Pressure
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1080/08037051.2025.2573034
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00